Curebase Unlocks Drug Development With Remote Clinical Trials; Raises $15M Led By GGV Capital
Curebase Unlocks Drug Development With Remote Clinical Trials; Raises $15M Led By GGV Capital News provided by Share this article Share this article SAN FRANCISCO, May 25, 2021 /PRNewswire/ -- Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor. The financing was led by GGV Capital with participation from Xfund, Bold Capital, and several other institutional funds, and brin...
Source: prnewswire.com